ArticleCureus2025
Radial Head Antibiotic Spacer for the Treatment of Prosthetic Joint Infection Following a Radial Head Arthroplasty: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prosthetic joint infection (PJI) following radial head arthroplasty (RHA) is a rare, yet devastating complication. Current treatment options for PJI comprise debridement, antibiotics, and implant retention (DAIR); resection arthroplasty; and one- or two-stage revision. Two-stage revision is the current gold standard for the treatment of PJI at the hip, shoulder, and knee, and involves using an antibiotic spacer to maintain limb length and soft tissue tension. Despite the widespread use of this technique in the treatment of PJI at other sites, its use in the treatment of RHA PJI has not been described. In this report, we illustrate the use of a novel polymethylmethacrylate (PMMA) spacer construct for the treatment of RHA PJI by the two-stage revision in a male patient. This method shows promising results, with the spacer maintaining structural integrity for four months.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.